Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
ABSTRACT - Project 3
A healthy immune system depends on T cells’ abilities to detect foreign agonist pMHC molecules, at near single
molecule levels, among vast numbers of sometimes very similar self-antigens. While the T cell’s fine
discrimination capabilities are experimentally well established, understanding how the molecular machinery of
the TCR signaling system achieves this is far from transparent. Fundamental issues of noise, variation, and
signal fidelity present serious challenges—both for understanding how the T cell works as well as for
development of therapeutic strategies utilizing T cells. Recently, a class of phenomena known as protein
condensation phase transitions have begun to emerge in biology. Originally identified in the context of nuclear
organization and gene expression, a distinct two-dimensional protein condensation on the cell membrane has
now been discovered in the T cell receptor (TCR) signaling system involving the scaffold protein LAT. While the
role of LAT as a scaffold for the clustering of downstream signaling molecules in T cells has long been
recognized, experimental realization that this structure can form through distinct types of phase transition
processes is more recent. Protein condensation phase transitions can exhibit a wide range of properties that
differ substantially from more linear molecular clustering processes, and thus offer a variety of different ways to
regulate the functional output of molecular signaling systems. Project 3 addresses the overarching
hypothesis that unique properties of the LAT protein condensation phase transition enable the
remarkable sensitivity and selectivity T cells exhibit during antigen recognition. We propose a series of
investigations to test aspects of this hypothesis that combine highly quantitative experiments in reconstituted
molecular systems with precision single-molecule live cell experiments in primary T cells. We have preliminary
data indicating that LAT condensation in live T cells is controlled by an unusual type of kinetic phase transition
and that specific molecular features of proximal TCR signaling are tuned to take advantage of this. Confirmation
and elucidation of this discovery will form the foundation of our more detailed investigation into the role of the
phase transition in TCR signaling. While Projects 1 and 2 focus on proximal signaling feedback mechanisms
leading up to LAT phosphorylation and condensate nucleation, and Project 4 examines signaling downstream
from the LAT condensate, Project 3 emphasizes experimental and computational characterization of the LAT
condensation phase transition itself and measurements of how its properties modulate downstream signal
propagation through the following specific aims: 1. Define the factors controlling initiation of LAT
condensation in T cells; 2. Engineer non-condensing LAT and LAT-like systems; 3. Define how LAT
condensates control downstream signaling to Ras and Ca2+ pathways. Insights originating from this work
will likely resolve some conceptual mysteries on mechanistic function of the T cell receptor signaling pathway
and highlight alternative angles to engineer and manipulate T cells for therapeutic benefit.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
15-July-2011
Project End Date
30-April-2027
Budget Start Date
01-May-2023
Budget End Date
30-April-2024
Project Funding Information for 2023
Total Funding
$386,378
Direct Costs
$318,760
Indirect Costs
$67,618
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Allergy and Infectious Diseases
$386,378
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P01AI091580-12 7546
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01AI091580-12 7546
Patents
No Patents information available for 5P01AI091580-12 7546
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01AI091580-12 7546
Clinical Studies
No Clinical Studies information available for 5P01AI091580-12 7546
News and More
Related News Releases
No news release information available for 5P01AI091580-12 7546
History
No Historical information available for 5P01AI091580-12 7546
Similar Projects
No Similar Projects information available for 5P01AI091580-12 7546